Tendo develops a medical exoskeleton for the 5% of the population that suffers from a limited hand function.

Initial sales will be directed to people who are paralyzed (spinal cord injury) as individually adapted devices. This allows early validation and traction, while having small scale sales with high sales-margins, in close discussion with the user. The device will then reach international markets efficiently by licensing to global players.